• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[长期通气患者流涎的治疗]

[Treatment of sialorrhea in patients under long-term ventilation].

作者信息

Winterholler M

机构信息

Neurologische Klinik, Krankenhaus Rummelsberg, Schwarzenbruck bei Nürnberg. winterholler. rummelsberger.net

出版信息

Pneumologie. 2008 Mar;62 Suppl 1:S39-42. doi: 10.1055/s-2007-1016440.

DOI:10.1055/s-2007-1016440
PMID:18317983
Abstract

Sialorrhea (drooling or excessive salivation) is a common problem in patients with progressive neurolomuscular diseases and bulbar palsy. Contributing factors are hypersecretion of saliva induced by cholinergic drugs and poor dental status. Non-invasive ventilation is often severely impaired in these patients. Treatment should be initiated with a thorough evaluation of the medication and of the oral status by an otorhinolaryngologist. As drooling is commonly caused by poor oral or pharyngeal neuromuscular control, swallowing therapy should be initiated by a speech therapist. Further treatment options are anticholinergic medications, botulinum toxin injections into the salivary gland, radiation and and surgical procedures. Whereas systemic anticholinergic medications lead often to side effects, the (ultrasound-guided) injection of botulinum toxin into the parotid and submandibular gland is a safe and effective method for controlling drooling for at least 2 months.

摘要

流涎(流口水或唾液分泌过多)是进行性神经肌肉疾病和延髓麻痹患者的常见问题。促成因素包括胆碱能药物引起的唾液分泌过多以及口腔状况不佳。这些患者的无创通气功能往往严重受损。应由耳鼻喉科医生对药物和口腔状况进行全面评估后开始治疗。由于流涎通常是由口腔或咽部神经肌肉控制不良引起的,因此应由言语治疗师开始吞咽治疗。进一步的治疗选择包括抗胆碱能药物、向唾液腺注射肉毒杆菌毒素、放射治疗和外科手术。虽然全身性抗胆碱能药物常常会导致副作用,但(超声引导下)向腮腺和下颌下腺注射肉毒杆菌毒素是一种安全有效的控制流涎至少2个月的方法。

相似文献

1
[Treatment of sialorrhea in patients under long-term ventilation].[长期通气患者流涎的治疗]
Pneumologie. 2008 Mar;62 Suppl 1:S39-42. doi: 10.1055/s-2007-1016440.
2
Sialorrhea: a management challenge.流涎:一项管理挑战。
Am Fam Physician. 2004 Jun 1;69(11):2628-34.
3
[The current approach to hyper-sialorrhea].[目前治疗流涎过多的方法]
Rev Belge Med Dent (1984). 2006;61(3):173-9.
4
Drooling of saliva: a review of the etiology and management options.流涎:病因及治疗选择综述
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jan;101(1):48-57. doi: 10.1016/j.tripleo.2005.08.018.
5
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.一项双盲、安慰剂对照研究,旨在评估A型肉毒杆菌毒素治疗帕金森病流涎的疗效和安全性。
Mov Disord. 2003 Jun;18(6):685-8. doi: 10.1002/mds.10420.
6
Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.肉毒杆菌毒素减少唾液分泌:33例流涎、唾液瘘和涎腺炎患者的扩展报告
Laryngoscope. 2004 Oct;114(10):1856-60. doi: 10.1097/00005537-200410000-00033.
7
Salivary gland application of botulinum toxin for the treatment of sialorrhea.肉毒杆菌毒素在唾液腺的应用治疗流涎症。
Med Oral Patol Oral Cir Bucal. 2007 Nov 1;12(7):E511-7.
8
Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.A型肉毒杆菌毒素治疗帕金森病流涎症:一项双盲、随机、安慰剂对照研究。
Mov Disord. 2006 May;21(5):704-7. doi: 10.1002/mds.20793.
9
Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.小儿慢性流涎症的外科治疗:一家三级医疗机构的10年经验
Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1387-92. doi: 10.1016/j.ijporl.2014.06.005. Epub 2014 Jun 16.
10
Botulinum toxin A in the treatment of sialorrhea.A型肉毒杆菌毒素治疗流涎症
Ann Pharmacother. 2007 Jan;41(1):79-85. doi: 10.1345/aph.1H381. Epub 2006 Dec 26.

引用本文的文献

1
Salivary Gland Botulinum Toxin a Injections for Treating Sialorrhea Among Critically Ill Patients With Neurological Disorders.唾液腺注射A型肉毒杆菌毒素治疗神经系统疾病重症患者的流涎症
Neurohospitalist. 2025 Apr 25:19418744251338148. doi: 10.1177/19418744251338148.